What is Aurinia Pharmaceuticals's contract liabilities?

Aurinia Pharmaceuticals (AUPH) reported contract liabilities of $12.65M in Q4 2025.

What does contract liabilities mean?

Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.

Aurinia Pharmaceuticals AUPH Contract Liabilities

Contract Liabilities at other companies

Kiniksa Pharmaceuticals International, plcKNSA

$31.81M0.0%

Alumis Inc.ALMS

$2.61M—

Mirum Pharmaceuticals, Inc.MIRM

$3.6M—

BridgeBio PharmaBBIO

$11.78M—

Ionis PharmaceuticalsIONS

$75.75M-46.2%

Arrowhead ResearchARWR

——

Other financials

Income statement

See full

Revenue$77.7M+24.4%

Gross profit$71.2M+32.1%

Operating income$41.4M+89.6%

Net income$34.4M+47.2%

EPS (diluted)$0.25+56.3%

Balance sheet

See full

Cash & equivalents$41.0M-38.3%

Total debt$85.2M-7.9%

Total equity$567.6M+62.1%

Total assets$724.0M+43.4%

Cash flow

See full

Operating cash flow$32.6M+2,405%

Valuation

See full

Market cap$2.39B+78.5%

Profitability

See full

Gross margin89.7%+1.5pp

Operating margin41.7%+29.4pp

Net margin100%+83.9pp

Returns & leverage

See full

Return on equity65%+53.8pp

Debt / equity0.2×-0.1×

Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: Aurinia Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's contract liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aurinia Pharmaceuticals's contract liabilities?: Aurinia Pharmaceuticals (AUPH) reported contract liabilities of $12.65M in Q4 2025.
What does contract liabilities mean?: Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.